Menu

Press Releases

Merck Receives Complete Response Letter from the U.S. FDA for TECOS Study with Sitagliptin

KENILWORTH, N.J. April 7, 2017 –(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter regarding Merck’s Supplemental New Drug Applications for JANUVIA® (sitagliptin), JANUMET® (sitagliptin and metformin HCl) and JANUMET XR® (sitagliptin and metformin HCl extended-release). […]

Allergan Names Daphne Karydas as Senior Vice President of Global Investor Relations & Strategy

, , ,

DUBLIN, April 6, 2017 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Daphne Karydas will join the Company as Senior Vice President of Global Investor Relations and Strategy, effective April 17, 2017. In this role, Ms. Karydas will lead the Company’s engagement with the investment community, and will work […]

Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agency

Company Receives EPA Honor for 12th Consecutive Year KENILWORTH, N.J. April 6, 2017 –(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that it has received an ENERGY STAR 2017 Partner of the Year – Sustained Excellence Award from the U.S. Environmental Protection Agency (EPA) for its continued improvement of […]

Merck to Present New Data on ZEPATIER® (elbasvir and grazoprevir) and Investigational Combination Therapy MK-3682B for the Treatment of Chronic Hepatitis C Infection at The International Liver Congress™ 2017

KENILWORTH, N.J. April 5, 2017 –(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that new data from the company’s chronic hepatitis C virus (HCV) clinical development programs as well as real-world studies on ZEPATIER® (elbasvir and grazoprevir) 50mg/100mg tablets will be presented at the upcoming International Liver Congress™ […]

Lilly and Ohio University Heritage College of Osteopathic Medicine Partner on Rotation Program for Medical Students

INDIANAPOLIS, April 4, 2017 /PRNewswire/ — Students from Ohio University’s Heritage College of Osteopathic Medicine will soon join Eli Lilly and Company’s (NYSE: LLY) innovative rotation program for aspiring physicians. Launched in early 2014, the program provides students with hands-on experience in a range of pharmaceutical business activities, from drug discovery and development to bioethics and […]

New Insight Illuminates How Cells Respond to Stress

Finding could lead to new approaches to fight cancer and slow the effects of aging DURHAM, N.C. April 4, 2017 – Duke Cancer Institute scientists have described a previously unknown series of steps that cells undergo when stressed, adding crucial information to the understanding of DNA damage that is at the heart of research into […]

Duke University Health System Lifts Flu Restrictions

DURHAM, N.C. April 4, 2017 – Due to a decrease in reported influenza activity, all Duke University Health System hospitals and ambulatory surgery centers have lifted the restrictions on patient visitations that were implemented on Feb. 10, 2017. Visitors to hospital and ambulatory surgery patients are still encouraged to follow standard flu precautions, including vaccination […]

NHRMC Outpatient Pharmacy Offers New Drop Box for Unused Medications

WILMINGTON, N.C. April 03, 2017 – To support the ongoing efforts of the New Hanover Regional Medical Center and South East Area Health Education Center (SEAHEC) Opioid Harm Reduction Initiative, the NHRMC Outpatient Pharmacy now has a medication disposal drop box available to patients, caregivers and visitors. This drop box provides patients with a convenient […]

Incyte and Merck Provide Additional Details on Previously Announced Collaboration Investigating Epacadostat and KEYTRUDA® (pembrolizumab)

Clinical Program Now Includes Seven Registrational Trials Across Five Tumor Types WILMINGTON, Del. & KENILWORTH, N.J. March 31, 2017 – Incyte Corporation (Nasdaq:INCY) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced additional details of their clinical development program investigating the combination of epacadostat, Incyte’s investigational oral selective IDO1 enzyme […]

«‹ 63 64 65 66›»